This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NxStage Enhances Patient Awareness Efforts With Launch Of Online Nephrologist Directory To Help Patients Connect With Local System One Prescribers

LAWRENCE, Mass., Nov. 22, 2011 /PRNewswire/ -- Taking control of your dialysis and finding the information you need about home hemodialysis with the NxStage ® System One just got easier for end stage renal disease (ESRD) patients with the launch of the NxStage Find a Doctor directory.  The on-line directory created by NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, makes it easier for patients to identify a nearby nephrologist with experience caring for home hemodialysis patients using the NxStage System One.  The Find a Doctor directory can be found under the " Home Hemodialysis" tab of NxStage's website.

(Logo: )

Today, the large majority of dialysis patients in the US receive conventional dialysis, which consists of treatment on a Monday/Wednesday/Friday or Tuesday/Thursday/Saturday schedule. This conventional in-center schedule leaves a 2-day gap between the last treatment of the preceding week and the first treatment of the following week, during which time toxins and fluids build up and may stress the heart and body.  Recent publications have shown this long gap between treatments is associated with increased patient hospitalization and mortality.

"With such an extensive pool of published data showing that, when compared with conventional thrice-weekly treatments, daily home hemodialysis can lead to improved health, quality of life and survival outcomes, the Find a Doctor Directory is an especially timely resource to encourage dialogue between patients and physicians who are knowledgeable about this treatment, empowering patients to explore all options for their kidney care," said Robert S. Lockridge, Jr., M.D., medical director of the UVA Home Dialysis program. "Dialysis patients should be informed of all treatment options and have access to the treatment that is right for them, including frequent home hemodialysis."

"Many patients and their families have told us that simplifying access to home hemodialysis would be very beneficial," said Jeffrey H. Burbank, Chief Executive Officer, NxStage Medical Inc. "As a patient focused organization, we believe that our new 'Find a Doctor' directory is a convenient tool to help interested patients identify a local nephrologist and pursue more frequent home hemodialysis.  We thank the many nephrologists that have chosen to collaborate with us in this important effort, and we look to continue to expand this in the future."

To search for a nephrologist, users provide their zip code to access a list of doctors within a designated radius, including contact information. With this information, users can reach out directly to the nephrologist's practice to learn more about more frequent home hemodialysis with the System One.  In addition to the Find a Doctor directory, users can also search the Find a Dialysis Center directory to locate a dialysis center offering training for the NxStage System One.


The Find a Doctor and Find a Dialysis Center directories are not intended as tools for verifying the credentials, qualifications, or abilities of any physician or center contained therein. The use of either directory by any entity or individual to verify the credentials of listed physicians or center is prohibited. Inclusion in either directory does not imply recommendation or endorsement by NxStage nor does omission in either directory imply NxStage disapproval.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs